Physician

Katherine Sanchez, MD

According to 2025 Medicare claims, Katherine Sanchez, MD (NPI: 1558740647) practices hematology/oncology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (NPI: 1164475232; TIN: 850367056) and primary practice location at 87109-4495. Sanchez is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Sanchez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 645 traditional Medicare patients, billed 97,871 HCPCS/CPT codes, and received $1,740,442 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 971 prescription claims across 235 beneficiaries totaling $1,807,197 in drug costs, led by Kisqali (Ribociclib Succinate). DME data shows 13 claims. Open Payments data shows 27 records totaling $93,496. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,460 to $1,740,442. Similarly, Part D prescription costs have risen steadily, from $8,685 to $1,807,197. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$870K$1.7M2018 Medicare payment: $5,460 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,785 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $267,152 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,483,304 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,740,442 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20183838$5,460
20192727$3,785
2020N/RN/RN/R
2021N/RN/RN/R
202217520,620$267,152
202358384,637$1,483,304
202464597,871$1,740,442

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$904K$1.8M2015 Drug cost: $8,685 (USD; Tot_Drug_Cst)2016 Drug cost: $20,325 (USD; Tot_Drug_Cst)2017 Drug cost: $18,663 (USD; Tot_Drug_Cst)2018 Drug cost: $10,551 (USD; Tot_Drug_Cst)2019 Drug cost: $756 (USD; Tot_Drug_Cst)2020 Drug cost: $3,307 (USD; Tot_Drug_Cst)2021 Drug cost: $5,122 (USD; Tot_Drug_Cst)2022 Drug cost: $77,205 (USD; Tot_Drug_Cst)2023 Drug cost: $1,168,831 (USD; Tot_Drug_Cst)2024 Drug cost: $1,807,197 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201556140$8,685
201696295$20,325
201768339$18,663
201836228$10,551
20191221$756
2020N/R34$3,307
20212071$5,122
202271147$77,205
2023181606$1,168,831
2024235971$1,807,197

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$114$2292024 Medicare payment: $229 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R13$229

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more254463$126
96413Administration of chemotherapy into vein, 1 hour or less87226$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more133139$92
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's334513$12
36415Insertion of needle into vein for collection of blood sample78102$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
KisqaliRibociclib Succinate26728$357,007
BrukinsaZanubrutinib21630$248,144
TagrissoOsimertinib Mesylate14420$220,548
VerzenioAbemaciclib13364$196,255
EliquisApixaban20780$14,448

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R13$229

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.23$5,427AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.4$88,069AstraZeneca Pharmaceuticals LP
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Katherine Sanchez, MD?

Tedicare shows public-source Medicare data for Katherine Sanchez, MD (NPI 1558740647), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Katherine Sanchez, MD have ACO affiliation data?

Katherine Sanchez, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Katherine Sanchez, MD?

Katherine Sanchez, MD is linked to NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS, LTD. (billing NPI 1164475232) in the available physician profile data.

Does Katherine Sanchez, MD have Open Payments data?

Katherine Sanchez, MD has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.